AMPHASTAR PHARMACEUTICALS INC Action · US03209R1032 · AMPH · A11664 (XNAS) États-Unis · Healthcare — cotations et cours en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Dernières analyses d’IA sur AMPHASTAR PHARMACEUTICALS INC

Résumé de la Note des Analystes

Conserver

Achat fort

Achat

Conserver

Vente

Vente forte

Pas de cours

17.08.2026 17:16

Cours actuels de AMPHASTAR PHARMACEUTICALS INC

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière
IEX	AMPH	USD	17.08.2026 17:16	20,92 USD	0,01 USD +0,05 %
NASDAQ	AMPH	USD	17.08.2026 17:00	20,98 USD	0,07 USD +0,33 %
Quotrix	APIRSD32.DUSD	EUR	31.07.2026 05:27	17,80 EUR	-
Düsseldorf	APIRSD32.DUSB	EUR	23.07.2026 17:30	16,63 EUR	-

Flottant et Liquidité des Actions

Flottant Libre 74,46 %

Actions en Flottant 32,83 M

Actions en Circulation 44,09 M

Fonds investis

Les fonds suivants ont investi dans AMPHASTAR PHARMACEUTICALS INC :

Fonds ETC 6 Meridian Small Cap Equity ETF	Vol. en millions 1.019,49	Part (%) 1,78 %
Fonds Invesco Pharmaceuticals ETF	Vol. en millions 6.512,83	Part (%) 1,77 %
Fonds State Street SPDR S&P Pharmaceuticals ETF	Vol. en millions 3.257,24	Part (%) 1,21 %
Fonds Pacer Funds Trust - Pacer Salt Low truBeta US Market ETF	Vol. en millions 56,33	Part (%) 0,91 %
Fonds Pacer Salt High truBeta US Market ETF	Vol. en millions 106,20	Part (%) 0,91 %

Profil de l'entreprise pour AMPHASTAR PHARMACEUTICALS INC Action

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.